SCHEMBL2907416

SCHEMBL2907416

CCOC(=O)c1cnc2cc(OC)c(N3CCN(C(C)C)CC3)cc2c1Nc1ccc(Cl)c(Cl)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 6/20 0.66
GAA P10253 6/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
SLC2A1 P11166 1/20 0.51
MAPT P10636 9/20 0.49
THRB P10828 2/20 0.48
SMN1; SMN2 Q16637 3/20 0.47
TP53 P04637 1/20 0.47
HTT P42858 3/20 0.47
LMNA P02545 2/20 0.47
MC4R P32245 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
PTK2B Q14289 1/20 0.47
EGFR P00533 1/20 0.47
KCNH2 Q12809 1/20 0.47
SCN5A Q14524 1/20 0.47
CLK1 P49759 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2907135 0.95 CSF1R (0.58) CSF1RGAAMEN1KMT2ASLC2A1
SCHEMBL2910657 0.91 CSF1R (0.79) CSF1RGAAMEN1KMT2ASLC2A1
SCHEMBL2913908 0.91 CSF1R (0.68) CSF1RGAAMEN1KMT2ASLC2A1
SCHEMBL2910769 0.91 CSF1R (0.68) CSF1RGAAMEN1KMT2ASLC2A1
SCHEMBL2911375 0.89 CSF1R (0.66) CSF1RGAAMEN1KMT2ASLC2A1
SCHEMBL2904973 0.89 CSF1R (0.83) CSF1RKCNH2SCN5A
SCHEMBL2912636 0.89 CSF1R (0.75) CSF1RGAAMEN1KMT2ASLC2A1
SCHEMBL2908777 0.88 CSF1R (0.79) CSF1RGAAMEN1KMT2ASLC2A1
SCHEMBL2911172 0.88 MAPT (0.52) CSF1RGAAMEN1KMT2AMAPT
SCHEMBL2914058 0.87 KCNH2 (0.63) CSF1RGAAMAPTTHRBKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2010496-B1 4-ANILINOQUINOLINE-3-CARBOXAMIDES AS CSF-1R KINASE INHIBITORS ASTRAZENECA AB (SE) 2010-08-25 EP disclosed